Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elobixibat to Facilitate Withdrawal from Stimulant Laxatives in Chronic Functional Constipation
jRCT1061210090Recruiting
- Sponsor
- Kazuhiro Kozuka
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of elobixibat in functional constipation (FC), sponsored by Kazuhiro Kozuka. Primary endpoint: Rate of withdrawal from regular use of stimulant laxatives. Started Mar 2022; status: recruiting.
02
Drugs
elobixibat
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on jRCT1061210090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061210090.